Clinical Trial Update: Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing budesonide and fluticasone for eosinophilic esophagitis has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Budesonide (BUDESONIDE)
• Fluticasone (fluticasone propionate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Eosinophilic Esophagitis | Phase 4 | Status: COMPLETED | Results posted: 2019-04-26